Evidence-Based Complementary and Alternative Medicine

Evidence-Based Complementary and Alternative Medicine / 2013 / Article
Special Issue

Complementary and Alternative Medicine for Respiratory Tract Infectious Diseases: Prevention and Treatments

View this Special Issue

Research Article | Open Access

Volume 2013 |Article ID 840719 | https://doi.org/10.1155/2013/840719

Balungile Madikizela, Ashwell Rungano Ndhlala, Jeffrey Franklin Finnie, Johannes Van Staden, "In Vitro Antimicrobial Activity of Extracts from Plants Used Traditionally in South Africa to Treat Tuberculosis and Related Symptoms", Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 840719, 8 pages, 2013. https://doi.org/10.1155/2013/840719

In Vitro Antimicrobial Activity of Extracts from Plants Used Traditionally in South Africa to Treat Tuberculosis and Related Symptoms

Academic Editor: Seong-Gyu Ko
Received12 Nov 2012
Accepted23 Jan 2013
Published05 Mar 2013

Abstract

Respiratory ailments are major human killers, especially in developing countries. Tuberculosis (TB) is an infectious disease causing a threat to human healthcare. Many South African plants are used in the traditional treatment of TB and related symptoms, but there has not been a sufficient focus on evaluating their antimicrobial properties. The aim of this study was to evaluate the antimicrobial properties of plants used traditionally to treat TB and related symptoms against microorganisms (Klebsiella pneumoniae, Staphylococcus aureus, and Mycobacterium aurum A+) associated with respiratory infections using the microdilution assay. Ten plants were selected based on a survey of available literature of medicinal plants used in South Africa for the treatment of TB and related symptoms. The petroleum ether, dichloromethane, 80% ethanol, and water extracts of the selected plants were evaluated for antibacterial activity. Out of 68 extracts tested from different parts of the 10 plant species, 17 showed good antimicrobial activities against at least one or more of the microbial strains tested, with minimum inhibitory concentration ranging from 0.195 to 12.5 mg/mL. The good antimicrobial properties of Abrus precatorius, Terminalia phanerophlebia, Indigofera arrecta, and Pentanisia prunelloides authenticate their traditional use in the treatment of respiratory diseases. Thus, further pharmacological and phytochemical analysis is required.

1. Introduction

A few decades ago, there was enormous optimism about the decline of threatening infectious diseases due to advances in technology and science [1]. However, due to a rise in the transitional nature of infectious diseases, such optimism has not yet been met. Worldwide infectious diseases are still the leading cause of death, especially in developing countries, claiming millions of lives yearly despite the enormous improvements made in human healthcare [2]. Globally, infectious diseases are the second leading cause of death of children and adults under the age of 50, placing severe burdens on the developing world [3, 4]. Within the last few decades, there has been the emergence of about 30 threatening infectious diseases with the majority capable of affecting humans [4]. The treatment of infectious diseases is facing a major problem at present with many microbes developing resistance to widely used antibiotics and antiviral therapies [57]. A few examples are the pathogens associated with acquired immunodeficiency syndrome (AIDS) and multidrug-resistant TB (MDRTB). In the coming years, emerging diseases will probably increase due to travel, urbanization, overcrowding, and inadequate healthcare leading to new interactions between human beings and animals as well as other diseases [8]. Thus, addressing the problem of infectious diseases is now an important and urgent requirement.

Respiratory diseases are among the major human killers in the world [9]. TB has been reported to be one of the most serious infectious bacterial diseases, causing a threat to healthcare globally despite the availability of drugs and care centres since the 1940s [7, 911]. TB is the most common cause of morbidity and mortality especially when co-infection with HIV-1 occurs and is a pandemic in many parts of the world [12]. TB is the most commonly notified disease in South Africa and the fifth largest cause of death [13, 14]. Approximately 285,000 cases of TB were estimated in South Africa in 2005, and it had the seventh highest population with TB in the world and the second in Africa [14].

Due to the important role medicinal plants play in the process of drug discovery and development, they are widely recognised as sources of active antimicrobial metabolites [11]. Several studies have been carried out in South Africa to record the ethnobotanical uses of plants in the treatment of tuberculosis and related symptoms such as coughing, respiratory ailments, and fever [11]. Examples of such detailed studies are recorded in useful reviews of medicinal plants by Watt and Breyer-Brandwijk [36]; Hutchings et al. [15], as well as Van Wyk et al. [17, 29]. Thus, there is a great potential in finding medicinal plants with activity against microorganisms related to respiratory infections.

Most studies done in South Africa on plants used traditionally to treat respiratory ailments have focused on evaluating their antimycobacterial activity against TB causing bacterial strains [13, 14, 37] but with little emphasis on the related symptoms [38, 39]. Therefore, this current study was aimed at evaluating the antimicrobial activity of selected plants against bacteria related to respiratory infection.

2. Materials and Methods

2.1. Selection and Preparation of Plants for Bioassays

Ten plants were selected based on the available literature of medicinal plants used by various South African tribes in the treatment of TB and related symptoms [11, 15, 17, 20, 29]. The plant materials were collected from the University of KwaZulu-Natal Botanical Garden and Ukulinga Research Farm. Voucher specimens were deposited in the University of KwaZulu-Natal (Pietermaritzburg) Herbarium (NU) for botanical authentication. The species name, family, traditional uses, voucher numbers, parts used, and previously screened activity of the plants used in the study are given in Table 1. The plant materials were oven-dried at 50°C, ground into powders, and stored in airtight containers. Dried plant material (10 g) was extracted sequentially with 200 mL of each of the four solvents, petroleum ether (PE), dichloromethane (DCM), 80% ethanol (EtOH), and water (from polar to nonpolar) by sonication for 1 h at 15°C with temperature being maintained by the addition of ice. The samples were then filtered through Whatman No. 1 filter paper and concentrated to dryness under reduced pressure using a rotary evaporator to obtain crude extracts. The aqueous extracts were dried under reduced pressure by means of a freeze-drier. Crude extracts were then stored in the dark at 10°C until use. The percentage yield for each extract was determined.


Family, speciesVoucher specimen numberTraditional useParts usedPreviously screened activityReferences

Amaryllidaceae
Brunsvigia   grandiflora  
Lindl.
BALUNGI 31Coughs and coldsBulbsMutagenic and antimutagenic activities of bulbs[15, 16]
Asparagaceae
Asparagus  africanus Lam.
BALUNGI 36Tuberculosis ShootsAnalgesic and anti-inflammatory activities of roots. Two antiprotozoal compounds were isolated
[15, 1719]
Asparagaceae Asparagus falcatus (L.) Oberm.BALUNGI 44Tuberculosis Leaves, rootsCaryophyllene-type sesquiterpene lactone isolated from the leaves was found to have remarkable effect on the proliferation (IC50 1.82 uM). Antibacterial activity of the roots
[2022]
Fabaceae
Abrus precatorius subsp. africanus Verdc.
BALUNGI 43Tuberculosis, bronchitis,
whooping cough, chest complaints, and asthma
Leaves, rootsSedative effects of roots. Antibacterial and cytotoxicity activity of seeds. Five compounds were isolated and identified as isoflavan, quinones, and hydroquinones[15, 2326]
Combretaceae
Terminalia phanerophlebia Engl. & Diels
BALUNGI 37TuberculosisRootsAntibacterial and antifungal activities of the leaves[20, 27]
Leguminosae
Indigofera arrecta Benth. ex Harv. & Sond.
BALUNGI 41Tuberculosis RootAntibacterial activity of the leaves[20, 28]
Moraceae
Ficus sur Forssk.
BALUNGI 39Tuberculosis/ulceration of the lungBark, rootAntimalarial and antibacterial activities of the leaves.
[15, 2931]
Polygalaceae
Polygala fruticosa P. J. Bergius
BALUNGI 35Tuberculosis, blood
purification, intestinal sores,sinusitis, and gonorrhoea
Whole plantAntibacterial activity against Gardnerella vaginalis and toxicity[11, 29, 32, 33]
Rubiaceae
Pentanisia
prunelloides
Schinz
BALUNGI 40
and 42
Tuberculosis, chest
pain, fever, and toothache
RootAntibacterial activity against B. subtilis, S. aureus, E. coli,and K. pneumonia. Antiviral activity of leaves and roots
[15, 29, 34]
Lamiaceae
Leonotis intermedia Lindl.
BALUNGI 38Colds, coughs, bronchitis,
asthma, tuberculosis, high blood pressure, and jaundice
Leaves, stemAnti-inflammatory activity[11, 35]

2.2. Bacterial Strains and Culture Conditions

Three strains of bacteria were used for antibacterial evaluation against the extracts. The strains were Klebsiella pneumoniae (ATCC 13883), Staphylococcus aureus (ATCC 12600), which were obtained from the American type culture collection, and Mycobacterium aurum A+ from the Microbiology Laboratory, Division of Pharmacology, University of Cape Town. The test organisms were selected because of their respiratory pathogenesis and fast growth rates [14, 40]. The strains were maintained on Mueller-Hinton (MH) agar except for M. aurum A+ which was maintained on Middlebrook 7H10 agar supplemented with 0.5% glycerol and 10% OADC (oleic acid, albumin, dextrose, and catalase).

2.3. Antimicrobial Activity Assays

The minimum inhibitory concentrations (MIC) of plant extracts were determined using the broth microdilution method in 96-well microtitre plates for S. aureus and K. pneumoniae as described by Eloff [41] and Jadaun et al. [42] for M. aurum A+. The extracts were dissolved in 10% DMSO except for aqueous extracts which were dissolved in sterile distilled water. The test organisms (S. aureus and K. pneumoniae) were cultured in MH broth for 24 h, while Middlebrook broth supplemented with 10% OADC and 0.5% glycerol was used to culture M. aurum A+ for 72 h at 37°C. Neomycin and streptomycin were used as the positive controls whereas broth, 10% DMSO, and water were used as negative controls. For antibacterial testing against S. aureus and K. pneumonia, 100 µL of water were added in each well and Middlebrook broth supplemented with 0.5% glycerol, and 10% OADC was used for M. aurum A+. One hundred microliters of solvent controls and test samples were added to the first wells of the microplate starting with a concentration of 100 mg/mL of extracts and 5 mg/mL for the positive control and then two-fold serially diluted down the wells. The optical density of S. aureus and K. pneumoniae was adjusted with MH broth to match that of McFarland standard, equivalent to colony forming units at 600 nm, and that of M. aurum A+ was adjusted to 0.125 at 550 nm using Middlebrook broth enriched with 0.5% glycerol and 10% OADC growth supplement. One hundred microliters of the diluted culture were added to all the wells. The microtitre plates were then incubated for 24 h at 37°C (S. aureus and K. pneumoniae) and for 72 h at 37°C (M. aurum A+). After incubation, 40 µL of p-iodonitrotetrazolium violet (INT) indicator (S. aureus and K. pneumoniae) and resazurin (M. aurum A+) were added to evaluate growth inhibition. The results were observed after 30 min for S. aureus and K. pneumoniae and 24 h for M. aurum A+. The lowest concentration containing blue (M. aurum A+) and clear wells (S. aureus and K. pneumoniae) were considered as the MIC values. The assay was repeated twice with two replicates per assay.

3. Results and Discussion

The plants selected in this study are all used in South African traditional medicine for the treatment of TB and related symptoms. The percentage yield and MIC values of the plant extract against K. pneumoniae, S. aureus and M. aurum A+ are presented in Table 2. The highest quantity of extract yield was observed from the EtOH extract of P. fruticosa, whilst the lowest one was from PE extracts of the roots of T. phanerophlebia. Generally, EtOH was the best extractant giving the highest mass of extracts while PE yielded the lowest mass. The masses of the water extracts were the second highest to EtOH for most of the species extracted. In this study, only MIC values equal to or less than 1.0 mg/mL for crude extracts were considered as exhibiting good activity [43]. Out of 68 extracts tested from different parts of 10 species, 17 were found to have good antimicrobial activities at least against one or more of the strains tested. Twelve extracts showed good activity against M. aurum A+ and 11 against S. aureus. It was observed that M. aurum A+ was the most susceptible bacterium while K. pneumoniae was the most resistant with only 6 extracts showing good activity. Due to lipopolysaccharides present on their outer membrane, Gram-negative bacteria are usually impermeable to most antibacterial compounds [44, 45]. This can explain the low number of active extracts against K. pneumoniae.


Plant speciesPlant partExtractExtract yield % (DW)Antibacterial activity MIC (mg/mL)
Klebsiella pneumoniae Mycobacterium aurum A+Staphylococcus aureus

A. precatorius subsp. africanus LPE1.0312.5012.5012.50
DCM1.2412.500.7812.50
80% EtOH3.543.130.1951.56
Water2.666.2512.503.13
SPE2.2812.5012.506.25
DCM2.8712.506.253.13
80% EtOH3.426.250.781.56
Water2.431.561.563.13

A. africanus LPE0.4012.506.2512.50
DCM0.5012.506.2512.50
80% EtOH1.506.250.396.25
Water6.801.566.2512.50

A. falcatus LPE0.8012.503.1312.50
DCM0.6212.501.5612.50
80% EtOH2.766.250.393.13
Water1.003.132.561.56

B. grandiflora BbPE2.8312.5012.5012.50
DCM0.9812.503.136.25
80% EtOH4.473.133.136.25
Water3.423.133.136.25

F. sur BPE0.5012.506.2512.50
DCM0.5012.506.3512.50
80% EtOH0.606.253.136.25
Water0.406.256.2512.50
RPE3.206.2512.512.50
DCM0.706.256.2512.50
80% EtOH7.700.783.130.195
Water2.1012.503.133.13

I. arrecta LPE2.666.2512.5012.50
DCM1.7912.506.2512.50
80% EtOH11.150.780.390.39
Water9.6912.500.786.25
RPE0.6012.506.2512.50
DCM0.7012.501.5612.50
80% EtOH11.403.131.561.56
Water0.806.3512.5012.50

L. intermedia LPE1.0212.506.2512.50
DCM1.0012.5012.5012.50
80% EtOH5.626.250.1950.78
Water3.203.133.131.56
StPE0.506.253.1312.50
DCM0.606.2512.5012.50
80% EtOH4.803.131.561.56
Water3.003.131.566.25

P. prunelloides LPE1.306.256.2512.50
DCM1.4012.5012.506.25
80% EtOH4.403.130.390.195
Water1.503.131.560.39
RPE0.206.253.1312.50
DCM0.206.2512.5012.50
80% EtOH11.400.390.780.78
Water6.761.561.561.56

P. fruticosa WpPE0.736.251.566.25
DCM1.046.251.566.25
80% EtOH16.673.133.131.56
Water4.843.133.136.25

T. phanerophlebia LPE0.506.256.256.25
DCM1.206.256.256.25
80% EtOH16.000.1951.560.195
Water9.800.390.390.098
RPE0.1012.506.2512.50
DCM0.306.253.136.25
80% EtOH12.901.563.130.195
Water1.703.136.250.39
TPE1.006.253.136.25
DCM0.406.251.563.13
80% EtOH11.000.1950.1950.39
Water3.701.561.561.56

Neomycin0.09750.0975
Streptomycin0.195

L: leaves, R: roots, B: bark, Bb: bulb, S: seeds, St: stem, Wp: whole plant, T: twigs, MIC: minimum inhibitory concentration, DCM: dichloromethane, PE: petroleum ether, EtOH: ethanol, % DW: percentage dry weight Values boldly written are considered very active.

The water extract of T. phanerophlebia (leaf) showed the best activity with the lowest MIC value of 0.098 mg/mL among the extracts tested. For water extracts only T. phanerophlebia leaves exhibited good activity against all bacterial species tested with MIC values ranging from 0.098 to 0.39 mg/mL. The water extracts of I. arrecta (leaf), P. prunelloides (leaf), and T. phanerophlebia (root) also showed good activity against at least one bacterial strain with MIC values ranging from 0.39 to 0.78 mg/mL. This was encouraging as many reports often state that water extracts lack bioactivity [46]. The evaluation of aqueous extracts aims to mimic the traditional use; therefore, the observed antibacterial activities exhibited by water extracts could be of interest. Such plants are candidates for further studies such as antimycobacterial evaluation against TB causing bacterial strains.

Comparing the root and leaf extracts of I. arrecta, the EtOH extracts of the leaf showed good antibacterial activity against all bacterial species tested with MIC values ranging from 0.39 to 0.78 mg/mL. For P. prunelloides leaves and roots, the EtOH extracts showed good activity with MIC values ranging from 0.195 to 0.78 mg/mL against almost all bacterial species tested. This is noteworthy as it indicates the presence of bioactive compounds in these plants that might help to isolate drugs that cure ailments related to respiratory infection. The palmitic acid previously isolated from roots of P. prunelloides by Yff et al. [34] could be responsible for the antimicrobial activity of this plant observed in this study. Yff et al. [34] also did an antiviral test on the root decoction of P. prunelloides and reported the inhibition of Influenza A virus. These results make this plant a potentially effective remedy against respiratory diseases, and the evaluation of palmitic acid against respiratory microbes is required.

For T. phanerophlebia leaf, root, and twig extracts, the EtOH extracts showed good activity against almost all bacterial strains tested with MIC values ranging from 0.098 to 0.39 mg/mL. This, however, was excluding the leaf extract that did not exhibit good activity against one strain and root extract that also did not show good activity against two strains. In a study on antimicrobial properties done by Shai et al. [27] against S. aureus, Escherichia coli, Enterococcus faecalis, and Pseudomonas aeruginosa, the leaf extracts of T. phanerophlebia exhibited good antimicrobial activity which was also the case in our study against the tested bacteria. In addition, in a literature investigation conducted by Nair et al. [47], several alkaloids were reported to have been isolated from the stem of T. phanerophlebia which exhibited cyclooxygenase-2 enzyme activity. The antimicrobial activity observed from different parts of this plant might be due to those alkaloids (cholestane triterpenoids -sitostenone, stigmast-4-ene-3,6-dione, and -sitosterol). It is, therefore, important to evaluate these compounds in bioassays against these microorganisms. Among the bark and root extracts of F. sur, only the EtOH extract (root) showed good activity with an MIC value of 0.78 mg/mL against K. pneumoniae and 0.195 mg/mL against S. aureus. The activity of this plant could be due to the triterpene compounds found in the latex isolated in a previous study by Feleke and Brehane [48], which also warrants testing in similar bioassays.

Among the leaf and stem of L. intermedia, the EtOH extract (leaf) showed good activity with MIC value of 0.195 against M. aurum A+ and 0.78 against S. aureus. These findings are very interesting as they indicate the antimicrobial activity of this plant. Of all the extracts of A. africanus and A. falcatus, good activity was observed only in the EtOH extracts with both having an MIC value of 0.39 mg/mL against M. aurum A+. Asparagus species are known to have steroidal saponins as their major bioactive constituents; therefore, the antimycobacterial activity of these two species of Asparagus could be due to saponins [49]. However, among all extracts of the leaves and seeds of A. precatorius subsp. africanus, only the EtOH (leaves and seeds) and DCM extracts (leaves) showed good activity with MIC values ranging from 0.195 to 0.78 mg/mL against M. aurum A+ only. Phytochemical research done in a previous study by Taur and Patil [50] from the root and aerial part of this plant showed the presence of triterpenoids and saponins. Saponins are known to have broad spectrum of pharmacological activities, including antimicrobial properties [51]. In view of the fact that these plants were selected based on their traditional uses against TB and related symptoms, these findings are noteworthy. However, all the extracts of B. grandiflora and P. fruticosa did not show good activity against all bacterial species tested despite being reported to be used in the treatment of TB and related symptoms. However, bioactivity cannot be completely ruled out from such plant species as they could be active against other bacterial strains that cause respiratory ailments. The other possible explanation could be that antimicrobial effects of these plants are not mediated through direct inhibition on microbial growth but rather through immunostimulation or the compounds potentially active require metabolic activation by certain enzyme in vivo [52].

4. Conclusion

Two or more extracts of A. precatorius subsp. africanus, T. phanerophlebia, I. arrecta, and P. prunelloides showed good antimicrobial activity against at least one or more of the bacterial strains tested. Therefore, the good antimicrobial properties of A. precatorius subsp. africanus, T. phanerophlebia, I. arrecta, and P. prunelloides found in this study form a good basis for further pharmacological (such as antimycobacterial evaluation against infectious TB microorganisms) and phytochemical investigation, and they validate the traditional use of these plants in the treatment of respiratory diseases in South Africa. The fact that some species of plants did not display good antimicrobial activity does not mean that they may have the same effect in vivo; thus, it should be noted that they only demonstrated weak activity in vitro. Additionally, weak activity might mean that the plant species are used to treat the symptoms of various respiratory ailments rather than the disease itself.

Acknowledgments

The National Research Foundation (NRF), Pretoria, Canon Collins GreenMatter Fellowship, Claude Leon Foundation, and the University of KwaZulu-Natal (UKZN) are thanked for providing financial support. The authors also wish to acknowledge Mrs. Alison Young (Horticulturist, UKZN) and Dr. Christina Curry, (Herbarium, NU) for the help in plant identification and the handling of herbarium specimens.

References

  1. M. L. Cohen, “Resurgent and emergent disease in a changing world,” British Medical Bulletin, vol. 54, no. 3, pp. 523–532, 1998. View at: Google Scholar
  2. T. York, H. de Wet, and S. F. Van Vuuren, “Plants used for treating respiratory infections in rural Maputaland, KwaZulu-Natal, South Africa,” Journal of Ethnopharmacology, vol. 135, no. 3, pp. 696–710, 2011. View at: Publisher Site | Google Scholar
  3. A. S. Fauci, “Infectious diseases: considerations for the 21st century,” Clinical Infectious Diseases, vol. 32, no. 5, pp. 675–685, 2001. View at: Publisher Site | Google Scholar
  4. M. A. Hamburg, “Considerations for infectious disease research and practice,” Technology in Society, vol. 30, no. 3-4, pp. 383–387, 2008. View at: Publisher Site | Google Scholar
  5. D. M. Morens, G. K. Folkers, and A. S. Fauci, “The challenge of emerging and re-emerging infectious diseases,” Nature, vol. 430, no. 6996, pp. 242–249, 2004. View at: Publisher Site | Google Scholar
  6. M. V. N. de Souza, “Promising candidates in clinical trials against multidrug-resistant tuberculosis (MDR-TB) based on natural products,” Fitoterapia, vol. 80, no. 8, pp. 453–460, 2009. View at: Publisher Site | Google Scholar
  7. Y. L. Chen, S. T. Huang, F. M. Sun et al., “Transformation of cinnamic acid from trans- to cis-form raises a notable bactericidal and synergistic activity against multiple-drug resistant Mycobacterium tuberculosis,” European Journal of Pharmaceutical Sciences, vol. 43, no. 3, pp. 188–194, 2011. View at: Publisher Site | Google Scholar
  8. E. Alirol, L. Getaz, B. Stoll, F. Chappuis, and L. Loutan, “Urbanisation and infectious diseases in a globalised world,” The Lancet Infectious Diseases, vol. 11, no. 2, pp. 131–141, 2011. View at: Publisher Site | Google Scholar
  9. A. Mann, J. O. Amupitan, A. O. Oyewale et al., “Evaluation of in vitro antimycobacterial activity of Nigerian plants used for treatment of respiratory diseases,” African Journal of Biotechnology, vol. 7, no. 11, pp. 1630–1636, 2008. View at: Google Scholar
  10. M. D. R. Camacho-Corona, M. A. Ramírez-Cabrera, O. González-Santiago, E. Garza-González, I. D. P. Palacios, and J. Luna-Herrera, “Activity against drug resistant-tuberculosis strains of plants used in Mexican traditional medicine to treat tuberculosis and other respiratory diseases,” Phytotherapy Research, vol. 22, no. 1, pp. 82–85, 2008. View at: Publisher Site | Google Scholar
  11. L. J. McGaw, N. Lall, J. J. M. Meyer, and J. N. Eloff, “The potential of South African plants against Mycobacterium infections,” Journal of Ethnopharmacology, vol. 119, no. 3, pp. 482–500, 2008. View at: Publisher Site | Google Scholar
  12. N. R. Gandhi, A. Moll, A. W. Sturm et al., “Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa,” The Lancet, vol. 368, no. 9547, pp. 1575–1580, 2006. View at: Publisher Site | Google Scholar
  13. N. Lall and J. M. Meyer, “In vitro inhibition of drug-resistant and drug-sensitive strains of Mycobacterium tuberculosis by ethnobotanically selected South African plants,” Journal of Ethnopharmacology, vol. 66, no. 3, pp. 347–354, 1999. View at: Publisher Site | Google Scholar
  14. E. Green, A. Samie, C. L. Obi, P. O. Bessong, and R. N. Ndip, “Inhibitory properties of selected South African medicinal plants against Mycobacterium tuberculosis,” Journal of Ethnopharmacology, vol. 130, no. 1, pp. 151–157, 2010. View at: Publisher Site | Google Scholar
  15. A. Hutchings, A. H. Scott, G. Lewis, and A. Cunningham, Zulu Medicinal Plants. An Inventory, University of Natal Press, Pietermaritzburg, South Africa, 1962.
  16. L. Verschaeve and J. Van Staden, “Mutagenic and antimutagenic properties of extracts from South African traditional medicinal plants,” Journal of Ethnopharmacology, vol. 119, no. 3, pp. 575–587, 2008. View at: Publisher Site | Google Scholar
  17. B.-E. Van Wyk, B. Van Oudtshoorn, and N. Gericke, Medicinal Plants of South Africa, Briza Publications, Pretoria, South Africa, 2nd edition, 2009.
  18. H. A. Oketch-Rabah, S. F. Dossaji, S. B. Christensen et al., “Antiprotozoal compounds from Asparagus africanus,” Journal of Natural Products, vol. 60, no. 10, pp. 1017–1022, 1997. View at: Publisher Site | Google Scholar
  19. H. S. Hassan, A. A. Ahmadu, and A. S. Hassan, “Analgesic and anti-inflammatory activities of Asparagus africanus root extract,” African Journal of Traditional, Complementary and Alternative Medicines, vol. 5, no. 1, pp. 27–31, 2008. View at: Google Scholar
  20. D. Mabogo, The ethnobotany of the Vha-Venda [M.S. thesis], University of Pretoria, Pretoria, South Africa, 1990.
  21. V. Steenkamp, A. C. Fernandes, and C. E. van Rensburg, “Antibacterial activity of Venda medicinal plants,” Fitoterapia, vol. 78, no. 7-8, pp. 561–564, 2007. View at: Publisher Site | Google Scholar
  22. R. M. . Ghalib, R. Hashim, O. Sulaiman et al., “A novel caryophyllene type sesquiterpene lactone from Asparagus falcatus (Linn.) structure elucidation and anti-angiogenic activity on huvecs,” European Journal of Medicinal Chemistry, vol. 47, no. 1, pp. 601–607, 2012. View at: Google Scholar
  23. G. B. Zore, V. Awad, A. D. Thakre et al., “Activity-directed fractionation and isolation of four antibacterial compounds from Abrus precatorius L. roots,” Natural Product Research, vol. 21, no. 10, pp. 933–940, 2007. View at: Publisher Site | Google Scholar
  24. R. Sivakumar and C. Alagesaboopathi, “Studies on cytotoxicity and antitumor screening of red and white forms of Abrus precatorius L,” African Journal of Biotechnology, vol. 7, no. 22, pp. 3984–3988, 2008. View at: Google Scholar
  25. G. E. K. Bolou, I. Bagré, K. Ouattara, and A. J. Djaman, “Evaluation of the antibacterial activity of 14 medicinal plants in côte d'ivoire,” Tropical Journal of Pharmaceutical Research, vol. 10, no. 3, pp. 335–340, 2011. View at: Publisher Site | Google Scholar
  26. Y. Hata, M. Raith, S. N. Ebrahimi et al., “Antiprotozoal isoflavan quinones from Abrus precatorius,” Planta Medica, vol. 78, no. 11, pp. 1277–1277, 2012. View at: Google Scholar
  27. L. J. Shai, L. J. McGaw, P. Masoko, and J. N. Eloff, “Antifungal and antibacterial activity of seven traditionally used South African plant species active against Candida albicans,” South African Journal of Botany, vol. 74, no. 4, pp. 677–684, 2008. View at: Publisher Site | Google Scholar
  28. J. C. Tomani, J. P. Nkurunziza, and M. J. Mukazayire, “Antidiarrhea activity and preliminary phytochemical screening of Indigofera arrecta, Cyathula uncinulata, Persea americana and Cupressus lusitanica,” Planta Medica, vol. 74, no. 9, pp. 956–956, 2008. View at: Google Scholar
  29. B.-E. Van Wyk, B. Van Oudtshoorn, and N. Gericke, Medicinal Plants of South Africa, Briza Publications, Pretoria, South Africa, 1997.
  30. I. M. S. Eldeen, E. E. Elgorashi, and J. Van Staden, “Antibacterial, anti-inflammatory, anti-cholinesterase and mutagenic effects of extracts obtained from some trees used in South African traditional medicine,” Journal of Ethnopharmacology, vol. 102, no. 3, pp. 457–464, 2005. View at: Publisher Site | Google Scholar
  31. F. W. Muregi, A. Ishih, T. Miyase et al., “Antimalarial activity of methanolic extracts from plants used in Kenyan ethnomedicine and their interactions with chloroquine (CQ) against a CQ-tolerant rodent parasite, in mice,” Journal of Ethnopharmacology, vol. 111, no. 1, pp. 190–195, 2007. View at: Publisher Site | Google Scholar
  32. S. F. Van Vuuren and D. Naidoo, “An antimicrobial investigation of plants used traditionally in southern Africa to treat sexually transmitted infections,” Journal of Ethnopharmacology, vol. 130, no. 3, pp. 552–558, 2010. View at: Publisher Site | Google Scholar
  33. J. T. Mukinda and P. F. K. Eagles, “Acute and sub-chronic oral toxicity profiles of the aqueous extract of Polygala fruticosa in female mice and rats,” Journal of Ethnopharmacology, vol. 128, no. 1, pp. 236–240, 2010. View at: Publisher Site | Google Scholar
  34. B. T. S. Yff, K. L. Lindsey, M. B. Taylor, D. G. Erasmus, and A. K. Jäger, “The pharmacological screening of Pentanisia prunelloides and the isolation of the antibacterial compound palmitic acid,” Journal of Ethnopharmacology, vol. 79, no. 1, pp. 101–107, 2002. View at: Publisher Site | Google Scholar
  35. A. K. Jäger, A. Hutchings, and J. Van Staden, “Screening of Zulu medicinal plants for prostaglandin-synthesis inhibitors,” Journal of Ethnopharmacology, vol. 52, no. 2, pp. 95–100, 1996. View at: Publisher Site | Google Scholar
  36. J. M. Watt and M. G. Breyer-Brandwijk, The Medicinal and Poisonous Plants of Southern Eastern Africa, Churchill Livingstone, Edinburgh, Scotland, 1962.
  37. S. P. N. Mativandlela, J. J. M. Meyer, A. A. Hussein, P. J. Houghton, C. J. Hamilton, and N. Lall, “Activity against Mycobacterium smegmatis and M. tuberculosis by extract of South African medicinal plants,” Phytotherapy Research, vol. 22, no. 6, pp. 841–845, 2008. View at: Publisher Site | Google Scholar
  38. L. V. Buwa and A. J. Afolayan, “Antimicrobial activity of some medicinal plants used for the treatment of tuberculosis in the Eastern Cape Province, South Africa,” African Journal of Biotechnology, vol. 8, no. 23, pp. 6683–6687, 2009. View at: Google Scholar
  39. T. York, S. F. Van Vuuren, and H. de Wet, “An antimicrobial evaluation of plants used for the treatment of respiratory infections in rural Maputaland, KwaZulu-Natal, South Africa,” Journal of Ethnopharmacology, vol. 144, no. 1, pp. 118–127, 2012. View at: Publisher Site | Google Scholar
  40. I. M. S. Eldeen and J. Van Staden, “Antimycobacterial activity of some trees used in South African traditional medicine,” South African Journal of Botany, vol. 73, no. 2, pp. 248–251, 2007. View at: Publisher Site | Google Scholar
  41. J. N. Eloff, “A sensitive and quick microplate method to determine the minimal inhibitory concentration of plant extracts for bacteria,” Planta Medica, vol. 64, no. 8, pp. 711–713, 1998. View at: Publisher Site | Google Scholar
  42. G. P. S. Jadaun, C. Agarwal, H. Sharma et al., “Determination of ethambutol MICs for Mycobacterium tuberculosis and Mycobacterium avium isolates by resazurin microtitre assay,” Journal of Antimicrobial Chemotherapy, vol. 60, no. 1, pp. 152–155, 2007. View at: Publisher Site | Google Scholar
  43. A. R. Ndhlala, G. I. Stafford, J. F. Finnie, and J. Van Staden, “In vitro pharmacological effects of manufactured herbal concoctions used in KwaZulu-Natal South Africa,” Journal of Ethnopharmacology, vol. 122, no. 1, pp. 117–122, 2009. View at: Publisher Site | Google Scholar
  44. C. W. Fennell, K. L. Lindsey, L. J. McGaw et al., “Assessing African medicinal plants for efficacy and safety: pharmacological screening and toxicology,” Journal of Ethnopharmacology, vol. 94, no. 2-3, pp. 205–217, 2004. View at: Publisher Site | Google Scholar
  45. S. Voravuthikunchai, A. Lortheeranuwat, W. Jeeju, T. Sririrak, S. Phongpaichit, and T. Supawita, “Effective medicinal plants against enterohaemorrhagic Escherichia coli O157:H7,” Journal of Ethnopharmacology, vol. 94, no. 1, pp. 49–54, 2004. View at: Publisher Site | Google Scholar
  46. R. B. Mulaudzi, A. R. Ndhlala, J. F. Finnie, and J. Van Staden, “Antimicrobial, anti-inflammatory and genotoxicity activity of Alepidea amatymbica and Alepidea natalensis (Apiaceae),” South African Journal of Botany, vol. 75, no. 3, pp. 584–587, 2009. View at: Publisher Site | Google Scholar
  47. J. J. Nair, A. O. Aremu, and J. Van Staden, “Anti-inflammatory effects of Terminalia phanerophlebia (Combretaceae) and identification of the active constituent principles,” South African Journal of Botany, vol. 81, pp. 79–80, 2012. View at: Google Scholar
  48. S. Feleke and A. Brehane, “Triterpene compounds from the latex of Ficus sur I,” Bulletin of the Chemical Society of Ethiopia, vol. 19, no. 2, pp. 307–310, 2005. View at: Google Scholar
  49. J. S. Negi, P. Singh, G. Joshi, M. S. Rawat, and V. Bisht, “Chemical constituents of Asparagus,” Pharmacognosy Reviews, vol. 4, no. 8, pp. 215–220, 2010. View at: Publisher Site | Google Scholar
  50. D. J. Taur and R. Y. Patil, “Mast cell stabilizing and antiallergic activity of Abrus precatorius in the management of asthma,” Asian Pacific Journal of Tropical Medicine, vol. 4, no. 1, pp. 46–49, 2011. View at: Publisher Site | Google Scholar
  51. S. G. Sparg, M. E. Light, and J. Van Staden, “Biological activities and distribution of plant saponins,” Journal of Ethnopharmacology, vol. 94, no. 2-3, pp. 219–243, 2004. View at: Publisher Site | Google Scholar
  52. X. Luo, D. Pires, J. Ainsa et al., “Antimycobacterial evaluation and preliminary phytochemical investigation of selected medicinal plants traditionally used in Mozambique,” Journal of Ethnopharmacology, vol. 137, no. 1, pp. 114–120, 2011. View at: Google Scholar

Copyright © 2013 Balungile Madikizela et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


More related articles

 PDF Download Citation Citation
 Download other formatsMore
 Order printed copiesOrder
Views10042
Downloads3256
Citations

Related articles

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.